Brands

Our Brands

Meitheal Pharmaceuticals is committed to solving unmet needs with the biopharmaceuticals industry by focusing on products that make a difference.

Antibiotics

Xenleta logo Prescribing Information
Product Website Prescribing Information

Immunology & Inflammation

XTMAB-16

More About XTMAB-16

Our Pipeline

  • All Products
  • Anti-Infective
  • Immunology & Inflammation
Download PDF
  • Discovery
  • Preclinical
  • Phase 1
  • Phase 2
  • Phase 3
  • Submission
  • Approved

Brands

Drug Name Therapeutic Area Type Discovery Preclinical Phase 1 Phase 2 Phase 3 Submission Approved
XENLETA® (lefamulin) Anti-Infective Small Molecule
Contepo™ (fosfomycin) for injection Anti-Infective Small Molecule
XTMAB-16 Immunology & Inflammation Biologic
You might also be interested

Generics

Slider image

Meitheal
Fertility

Slider image

The brands mentioned here are the trademarks of their respective owners.

This Website Uses Cookies

This website uses cookies to help give you the best experience when you visit. By clicking “Accept Cookies,” you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and help us make improvements to our site. You can read more about our use of cookies in our Privacy Policy.

Manage Consent Preferences

Always Active

Necessary cookies enable core functionality such as security and accessibility. You may disable these by changing your browser settings, but this may affect how the website functions.

These cookies are set to provide quantitative measures of website visitors. Information collected with these cookies is used in operations to measure website performance. With the usage of these cookies we are able to count visits and traffic sources to improve our site. The data is collected in a way that does not directly identify anyone.
Accept all cookies Confirm my choices